Healthcare giant Grifols accused of manipulating finances by short seller Gotham City, stock plummets
Plasma-derived medicines manufacturing company Grifols has been accused of manipulating its reported debt and EBITDA by UK-based hedge fund Gotham City Research, causing its stock …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.